• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • Q&A
    • Videos
    • Comment
    • Analysis
    • People moves
    • In Profile
  •  
    Analysis
    • Videos
    • Q&A
    • Comment
    • In Profile
    • Podcast
    • Fundraising
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Healthcare

EQT in exclusivity to acquire Cerba from Partners Group
EQT in exclusivity to acquire Cerba from Partners Group

Medical diagnostics business has previously been backed by sponsors including Astorg, IK and PAI

  • Buyouts
  • 31 March 2021
Gyroscope Therapeutics raises $148m in Forbion-led series C
Gyroscope Therapeutics raises $148m in Forbion-led series C

Series-C round for the gene therapy company is led by Forbionт€™s Growth Opportunities Fund

  • Early-stage
  • 29 March 2021
Aksia buys Medical International Research
Aksia buys Medical International Research

GP invests in the company via Aksia Capital V, which targets European businesses with potential for high-growth

  • Buyouts
  • 26 March 2021
ICG invests in $80m round for Eliem Therapeutics
ICG invests in $80m round for Eliem Therapeutics

This is the first investment made by ICG Life Sciences, which was launched in January 2021

  • Investments
  • 25 March 2021
Nordic Capital acquires minority stake in Leo Pharma
Nordic Capital acquires minority stake in Leo Pharma

GP's stake is reportedly smaller than 25%, with the current owner remaining as the majority shareholder

  • Expansion
  • 24 March 2021
Miura backs dental specialist Proclinic
Miura backs dental specialist Proclinic

GP plans to boost the company's growth in Spain and bolster its international expansion, primarily in Italy and France

  • Buyouts
  • 23 March 2021
SEP sells Dotmatics to Insight Partners' Insightful Science
SEP sells Dotmatics to Insight Partners' Insightful Science

Scottish Equity Partners invested in the scientific informatics software in 2017

  • Exits
  • 23 March 2021
Capiton heads for summer final close for sixth fund
Capiton heads for summer final close for sixth fund

Capiton VI has a €550m target; Capiton V held a final close in January 2015 on €440m

  • Buyout
  • 18 March 2021
Albion exits Berkley Care for 2.5x return
Albion exits Berkley Care for 2.5x return

Sale ends a seven-year holding period for Albion, which initially invested ТЃ16m in the business

  • Exits
  • 17 March 2021
Magnum exits Ita Mental Health to Korian
Magnum exits Ita Mental Health to Korian

Sale ends a four-year holding period for the GP, which invested in the company via Magnum Capital II

  • Exits
  • 17 March 2021
Triton Smaller Mid-Cap Fund II closes on €815m
Triton Smaller Mid-Cap Fund II closes on €815m

Fund will follow the same sector and value-creation strategy as TSM I, albeit with larger equity tickets

  • Buyout
  • 16 March 2021
Capiton buys majority stake in Wundex
Capiton buys majority stake in Wundex

Wound care product supplier was a portfolio company of BE Beteiligungen prior to the sale to Capiton

  • Buyouts
  • 15 March 2021
CVC buys Cooper from Charterhouse for €2.2bn
CVC buys Cooper from Charterhouse for €2.2bn

CVC invests via fund VII, while Charterhouse will reinvest in the OTC pharmaceuticals business

  • Buyouts
  • 12 March 2021
ICG acquires Lucid Group from LDC
ICG acquires Lucid Group from LDC

Sale ends a four-year holding period for LDC, which invested ТЃ11m in the company in exchange for a minority stake

  • Exits
  • 11 March 2021
Claris Ventures leads £15.2m series-B for NeoPhore
Claris Ventures leads £15.2m series-B for NeoPhore

2Invest, 3B Future Health Fund, Astellas Venture Management and CRT Pioneer Fund also take part in the round

  • Early-stage
  • 10 March 2021
Triton invests in NPM Capital's Bergman Clinics
Triton invests in NPM Capital's Bergman Clinics

Investment is being made in partnership with NPM Capital and the Malenstein family

  • Buyouts
  • 09 March 2021
DCVC Bio leads $17m series-A round for BioPhero
DCVC Bio leads $17m series-A round for BioPhero

Startup will use the funding to start production of its first product and make it available worldwide

  • Early-stage
  • 09 March 2021
BlackRock joins $100m series-C funding for Exscientia
BlackRock joins $100m series-C funding for Exscientia

Company plans to use the financing to expand its portfolio of drugs and grow its artificial intelligence capabilities

  • Expansion
  • 05 March 2021
Pride Capital sells stake in Kairos to trade
Pride Capital sells stake in Kairos to trade

Direct lender invested in Kairos in 2018 and was part of Main Capital until its spin-out in 2019

  • Exits
  • 04 March 2021
KKR invests $100m in Nordic Bioscience
KKR invests $100m in Nordic Bioscience

GP is investing from Health Care Strategic Growth Fund, which held a final close in November 2017 on $1.2bn

  • Expansion
  • 04 March 2021
Summa-backed Olink files for US IPO
Summa-backed Olink files for US IPO

Olink has been backed by Summa Equity since March 2019 and increased its revenues by 16.7% in 2020

  • Exits
  • 04 March 2021
Biotech market provides dose of optimism
Biotech market provides dose of optimism

In the past year, the biotech market has seen buoyant activity, reaching record levels of investments

  • Healthcare
  • 03 March 2021
Kartesia takes control of ADL Biopharma
Kartesia takes control of ADL Biopharma

Company's board of directors is reduced to three seats and Ignacio Urbelz is appointed as new CEO

  • Expansion
  • 02 March 2021
Siparex buys Winncare from IDI
Siparex buys Winncare from IDI

Capza takes part in the deal alongside Siparex and acquires a minority stake

  • Buyouts
  • 23 February 2021
192021
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013